ENTITY
Consun Pharmaceutical

Consun Pharmaceutical (1681 HK)

59
Analysis
Health Care • China
Consun Pharmaceutical Group is a modern pharmaceutical enterprise engaged in the research, development, production, and marketing of modern Chinese medicines and medical imaging contrast mediums. It also manufactures and sells traditional Chinese medicines. Key products include Uremic Clearance Granule for kidney disease, Gadopentetate Dimeglumine Injection as a medical contrast medium, and Iron Dextran Oral Solution. The company was founded in 1997 and is headquartered in Guangzhou, China.
more
•16 Oct 2018 21:46

Consun Pharma (1681): 1H 2018 Update and Overseas Venture

Since my last note on Consun Pharmaceutical (1681 HK) , its share price has tanked by 36.31%; fell much harder compared to Hong Kong Hang Seng...

Logo
514 Views
Share
•24 Jul 2018 15:19

China Shineway(2877: HK): Beneficiary from Deregulation of Non-Essential Drug in Grassroots Level

A year ago, I wrote about China Shineway Pharmaceutical Group Ltd. (2877 HK) that has a couple of low-cost drugs that sell in the second and third...

Logo
657 Views
Share
•06 Jun 2018 16:02

Consun Pharma: A Call with Management Reveals More Value

Consun Pharmaceutical Group (1681 HK) share price fell 8% on the 31st May 2018, while their YTD performance is still +20%, outperforming both Hong...

Logo
446 Views
Share
•25 May 2018 07:58

Consun Pharma: Gaining Popularity Globally Through Martial Art?

Consun Pharmaceutical Group (1681 HK) subsidiary is Guangxi Yulin whose flagship product is Zheng Gu Shui, literally translated as bone fixing...

Logo
229 Views
Share
•16 Apr 2018 23:17

Consun: It's Not Expensive and More to Come

The combination of traditional and modern pharmaceutical philosophy seems to work well for Consun Pharmaceutical Group (1681 HK), it recorded 35.7%...

Logo
246 Views
Share
x